超声造影在早期动脉粥样硬化疾病的研究进展  

Research Progress of Contrast-Enhanced Ultrasound in Early Atherosclerosis Disease

作　　者：孙瑜[1] 李想[1] 罗春英 刘佳[1] 薛莉[1] SUN Yu LI Xiang LUO Chun-ying LIU Jia XUE Li(Ultrasound Division, Department of Cardiology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China Department of Ultrasound, Chest Hospital of Harbin, Harbin, Heilongjiang, 150056, China)

机构地区：[1]哈尔滨医科大学附属第四医院心内超声室,黑龙江哈尔滨150001 [2]哈尔滨市胸科医院超声科,黑龙江哈尔滨150056

出　　处：《现代生物医学进展》2017年第10期1960-1963,共4页Progress in Modern Biomedicine

基　　金：国家自然科学基金项目(81571690)

摘　　要：动脉粥样硬化一直是心血管医学面临的长期而严峻的挑战,随着代谢性危险因素的日益增多,动脉粥样硬化性疾病带来的危害日益突出;超声成像作为一种良好的无创、实时检查手段,一直作为动脉粥样硬化疾病诊断的首选诊断方法;近30年来超声影像学快速发展,从过去单纯对发生粥样硬化损伤的血管结构进行成像,经过各方面技术的发展,如今其对动脉粥样硬化组织内的结构以及病理过程的显像已成为可能。在本文中,将对近年来超声造影在早期AS疾病的诊治及疗效评价方面的进展作简要综述。Atherosclerosis has been known as the biggest challenge in vascular medicine. With the metabolic factor of danger rising, more harm that brought from the atherosclerotic disease will show up. Ultrasound imaging, as the noninvasive and real-time inspection method, is always used as the atherosclerotic diagnosis tool. Revolution in the field of ultrasound imaging in the last three decades has enabled imaging of the pathological process and structure within atherosclerotic tissue. In this article, we review advances in contrast-enhanced ultrasound aimed at detecting the lesion at the relatively early stage of atherosclerosis.

关 键 词：动脉粥样硬化 超声成像 分子影像 超声造影剂 

分 类 号：R543.5[医药卫生—心血管疾病] R445.1[医药卫生—内科学]